The Company is expanding its intellectual property portfolio to protect its single chip non-invasive mmWave RF sensor technology, which will be the foundation of its future wearable devices
Movano Inc. (Nasdaq: MOVE), a health technology company designing devices that inspire and empower you to live a healthier, happier life, announced it has been awarded three new U.S. patents, increasing its total number of issued U.S. patents to six. The Company also has more than 40 pending U.S. and International applications. The patents and pending patent applications are related to innovations around Movano’s non-invasive sensor technology, which combines Radio Frequency (RF) and mmWave capabilities onto a single Integrated Circuit (IC) that will be integrated into various wearable devices in the future.
“As Movano progresses toward bringing RF-enabled, non-invasive health wearables that will measure glucose, blood pressure and other vital health data to the market, we have been prolifically filing patents to protect our core technology,” said Dr. John Mastrototaro, CEO of Movano Inc. “Over the past several years, we have been building an innovative architecture for a single multi-band IC in order to provide health conscious consumers with accurate health data. We’ve developed, and now patented, innovations that utilize unprecedented signal diversity and advanced signal processing capabilities to produce rich data sets that will allow us to deliver on these promises and differentiate from the competition.”
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to AI-Techpark.com.
